Alexander Stein, Prof. Dr.

Trials

Studies that name Alexander Stein, Prof. Dr. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:56 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07176312 · Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

  Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · recruiting · Gastroesophageal Adenocarcinoma, First Line Therapy, HER2 + Gastric Cancer · principal investigator
• Ph2
  NCT06856837 · - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

  Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · recruiting · Metastatic Colorectal Cancer · principal investigator
• Ph2
  NCT05510895 · Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer

  AIO-Studien-gGmbH · completed · Colorectal Cancer, Colon Cancer, BRAF V600E · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 29 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.